ESC Clinical Practice Guidelines on The Management of Chronic and Acute Heart Failure:
KEYWORDS: heart, failure, heart failure, people, symptoms, treatment, hfref, medications, improve, help, devices, hfpef, healthcare, left, physical

of the heart muscle called cardiomyopathy, may be ‘hereditary’, meaning they can be passed down in your family. Genetic testing should be considered in people who may have cardiomyopathy depending on age, family history and heart structure. Treatment for Heart Failure Care from a multidisciplinary team (healthcare professionals across different specialities) is key to meeting the three major goals of treatment for people with heart failure: 1. longer life 2. prevent hospital stays due to worsening heart failure 3. decrease symptoms and improve quality of life Some of the ways that you and your multidisciplinary team can help to achieve these goals are shown below: Multidisciplinary team Management Medication Devices Surgery Lifestyle and monitoring Help patients live longer, prevent hospital stays, decrease symptoms and improve quality of life Medications for People with HFrEF Medicines are the first treatment for HFrEF and should be started as early as possible, before devices or other non-medicinal treatments are used. The ESC Clinical Practice Guidelines currently recommend four different types of medicines for people with HFrEF: Angiotensin converting enzyme inhibitors (ACE-I) or angiotensin receptor neprilysin inhibitors (ARNI), beta-blockers (BB), mineralocorticoid receptor antagonists (MRA) and sodium-glucose cotransporter-2 (SGLT2) inhibitors. The table below explains how the
